Once recognizing the lipids presented by CD1d or infiltrated into tumor sites with chemokines such as CCL2 and CCL20, iNKT cells are activated and exhibit antitumor activity through direct lysis of target cells or releasing of cytokines, which recruit other immune cells to the TME and potentiated tumor‐specific immunity. The gene discussed is CD1D; the disease is neoplasm.